We report on the properties of a temperature-sensitive mutant produced by transfection of cells with intact DNA and a specific DNA fragment mutagenized with low levels of hydroxylamine. The plating efficiency of the mutant at 390C relative to that at 33.50C was 5 x 10'. The pattern of polypeptides produced at the nonpermissive temperature was similar to that seen with wild-type virus in infected cells treated with inhibitory concentrations of phosphonoacetic acid in that a and ,B polypeptides were produced, whereas most y polypeptides were either reduced or absent. Consistently, the mutant did not make viral DNA, although temperature sensitivity of the viral DNA polymerase could not be demonstrated. Marker rescue studies with herpes simplex virus type 2 (HSV-2) DNA mapped the mutant in the L component within map positions 0.385 and 0.402 in the prototype (P) arrangement of the HSV-1 genome. Analysis of the recombinants permitted the mapping of the genes specifying infected cell polypeptides 36, 35, 37, 19.5, 11, 8, 2, 43, and 44, but only the infected cell polypeptide 8 of HSV-2 was consistently made by all recombinants containing demonstrable HSV-2 sequences. Marker rescue studies with cloned HSV-1 DNA fragments mapped the temperature-sensitive lesion within less than 103 base pairs between 0.383 and 0.388 map units. Translation of the RNA hybridizing to cloned HSV-1 DNA, encompassing the smallest region containing the mutation, revealed polypeptide 8 (128,000 molecular weight), which was previously identified as a /8 polypeptide with high affinity for viral DNA, and a polypeptide (25,000 molecular weight) not previously identified in lysates of labeled cells.
We report on the properties of a temperature-sensitive mutant produced by transfection of cells with intact DNA and a specific DNA fragment mutagenized with low levels of hydroxylamine. The plating efficiency of the mutant at 390C relative to that at 33.50C was 5 x 10'. The pattern of polypeptides produced at the nonpermissive temperature was similar to that seen with wild-type virus in infected cells treated with inhibitory concentrations of phosphonoacetic acid in that a and ,B polypeptides were produced, whereas most y polypeptides were either reduced or absent. Consistently, the mutant did not make viral DNA, although temperature sensitivity of the viral DNA polymerase could not be demonstrated. Marker rescue studies with herpes simplex virus type 2 (HSV-2) DNA mapped the mutant in the L component within map positions 0.385 and 0.402 in the prototype (P) arrangement of the HSV-1 genome. Analysis of the recombinants permitted the mapping of the genes specifying infected cell polypeptides 36, 35, 37, 19.5, 11, 8, 2, 43 , and 44, but only the infected cell polypeptide 8 of HSV-2 was consistently made by all recombinants containing demonstrable HSV-2 sequences. Marker rescue studies with cloned HSV-1 DNA fragments mapped the temperature-sensitive lesion within less than 103 base pairs between 0.383 and 0.388 map units. Translation of the RNA hybridizing to cloned HSV-1 DNA, encompassing the smallest region containing the mutation, revealed polypeptide 8 (128,000 molecular weight), which was previously identified as a /8 polypeptide with high affinity for viral DNA, and a polypeptide (25,000 molecular weight) not previously identified in lysates of labeled cells.
Approximately 50 infected cell polypeptides (ICPs) produced in cells infected with either herpes simplex virus type 1 (human herpesvirus 1, HSV-1) or HSV-2 appear to be virus specific (12, 25) . The functions of some of the ICPs have been identified (33) , but the functions of the majority of the ICPs are not known. One approach to the identification of the functions of these polypeptides is the production of functional mutants by mutagenesis of the entire genome (4, 5, 32) or of selected regions (6) of the viral DNA. In this paper, we report the production and characterization of a temperature-sensitive mutant produced by mutagenesis of a restriction endonuclease fragment of HSV-1 DNA.
The mutation appeared to map within the coding sequences specifying two viral polypeptides mmol), [ Preparation of viral DNA and restriction endonuclease digestion. Intact viral DNA was purified by NaI density gradient centrifugation (36) of DNA extracted from cytoplasmic nucleocapsids or from infected whole cell lysates. Digestion of viral DNA, preparative agarose gel electrophoresis, and isolation of individual restriction endonuclease-derived fragments were described elsewhere (22) . Analytical gel electrophoresis was done on a horizontal apparatus at 2 V/cm. In some experiments, BamHI HSV-1 DNA fragments cloned in pBR322 (24) were used. These were BamHI-G (pRB102), BamHI-Q (pRB103), and BamHI-T (pRB119). The plasmids carrying the cloned HSV-1(F) DNA were extracted from bacteria and centrifuged to equilibrium in cesium chlorideethidium bromide gradients as described elsewhere (7) .
The plasmid pRB401 contained the HSV-1(F) sequences mapping between the SalI cleavage site at 0.372 map units and the BamHI cleavage site at 0.388 map units and enclosed the left portion of the SalI fragment 0 (AO) (Fig. 1) . To construct the plasmid, pRB102 was digested with SalI, annealed, ligated in 66 mM Tris (pH 7.6), 6 mM MgCl2, 10 mM dithiothreitol, 0.5 mM ATP, and 1.0 U of T4 DNA ligase, and used to transform Escherichia coli C600SF8 as described (20) . pRB401 was propagated and purified as described elsewhere (24) .
Mutagenic treatment ofthe DNA fragment and isolation of the temperature-sensitive mutant.
The BglII fragment I (molecular weight, 10 (15) . The 37, 1981 polyacrylamide gel electrophoresis of the cell lysates, and autoradiography were performed as previously described (23) .
RESULTS
Isolation of the temperature-sensitive mutant. Approximately 300 plaques were isolated from the viral progeny obtained after transfection of the rabbit skin cells with the hydroxylamine-treated BglII fragment I and intact HSV-l(fm-P) DNA. A single stable mutant, designated HSV-1(miP)tsHAl and exhibiting a ratio of plating efficiencies (39/33.5°C) of 5 x 10-6, was selected for further studies. HSV-1(mnxP)tsHA1, like its parent HSV-l(mP), has syn+ plaque morphology (11) .
Characterization of tsHAl: DNA synthesis. Two series of experiments were done. The purpose of the first experiment was to determine whether the ts lesion in HSV-1(miP)tsHA1 has an effect on viral DNA synthesis. The incorporation of [3H]thymidine into viral DNA was measured at both 33.5 and 390C, the permissive and nonpermissive temperatures, respectively. The results of the NaI equilibrium density centrifugation of the DNA extracted from labeled infected cells are shown in Fig. 2 . Both HSVl(mP) and HSV-1(fm-P)tsHAl synthesized viral DNA at 33.5°C. In contrast to the parent HSVl(mn-P), the mutant failed to synthesize viral DNA in cells infected and maintained at the nonpermissive temperature. In addition, there was no viral DNA synthesis in either HSVl(mP)-or HSV-1(mnP)tsHA1-infected cells at either temperature in the presence of 300 ,ug of PAA per ml (data not shown).
In the second series of experiments, we tested the temperature sensitivity of the DNA polymerase. In the first experiment, replicate cultures were infected with mutant or parental virus, incubated for 12 h at the permissive temperature, and then extracted and inactivated at 390C
for intervals up to 30 min. Analyses of viral DNA polymerase activity failed to show preferential inactivation of the polymerase specified by the mutant. In the second experiment, cells infected with mutant or parental virus were shifted from 33.5 to 39°C at 12 h postinfection. At hourly intervals, up to 16 h postinfection, replicate cultures were harvested and cell extracts were tested for DNA polymerase activity. No differences in DNA polymerase activity between parent-and mutant-infected cells were found. These studies indicated that the mutation was not in the viral DNA polymerase. Characterization of tsHAl: protein synthesis at the permissive and nonpermissive temperatures. In this series of experiments, replicate HEp-2 cultures were infected with HSV-l(fm-P) or HSV-l(fn-P)tsHAl and incubated at 33.5 and 39°C. At various times postinfection, the cells were labeled for 2-h intervals with "ICamino acids. Autoradiographic images of the electrophoretically separated polypeptides are shown in Fig. 3 . The most obvious feature of the results was the reduction in the synthesis of y polypeptides during the 10-to 12-h labeling interval in cells infected with the mutant virus and incubated at 39°C. Specific y polypeptides, e.g., ICPs 15, 19, 20, 37 The electrophoretic profile seen at the nonpermissive temperature in HAl-infected cells was similar to that seen in cells infected with PAA-sensitive virus in the presence of PAA (Fig.  4) . This figure shows that the inhibition of viral DNA synthesis resulted in reduction in the synthesis of y polypeptides ICPs 5, 25, 29, 32, and 33 and the absence of -y polypeptides ICPs 15, 19, 20, 43 , and 44. Therefore, the effect of the mutation in HA1 on late protein synthesis might be mediated by the inhibition of viral DNA synthesis at the nonpermissive temperature.
Physical mapping of the temperaturesensitive lesion: rescue with HSV-2 (G) restriction endonuclease digests. The purpose of this series of experiments was to locate the approximate region of the genome containing the HAl lesion and to identify the polypeptides whose genes are located at or near the mutated site. The mapping of the lesion was based on observations that the restriction endonuclease maps of HSV-1 and HSV-2 differ (10) and that HSV-2 sequences will substitute for HSV-1 sequences in marker rescue tests (18, 35) .
Rabbit skin cell cultures were transfected with a mixture of HSV-1(mnP)tsHA1 DNA and restriction endonuclease-digested HSV-2(G) DNA. The HSV-2 DNA was digested with either HsuI, EcoRI, or BglII. The results of the titrations of the transfection stocks are presented in Table 1 . The HSV-2(G) DNA digested with either HsuI or EcoRI rescued the mutant DNA. However, there was no rescue with HSV-2(G) DNA digested with BglII, possibly because there is a BglII cleavage site in HSV-2(G) DNA at map position 0.387 (see Fig. 7 ), i.e., within the minimal map coordinates in which the mutation has been mapped as described below. The number of stable ts+ isolates obtained from the EcoRI and HsuI rescue stocks and used in further experiments is also listed in Table I . Four isolates from the HsuI digest rescue stocks and eight from the EcoRI digest rescue stocks were analyzed. The plaque-purified rescued clones were numbered serially and prefixed with the designation RH1G, denoting that these are recombinants produced by rescue of the HAl mutant with HSV-2(G) DNA.
The DNAs of these ts+ recombinants were digested with the restriction endonucleases BamHI, HpaI, BglII, and KpnI. The electrophoretically separated BamHI and KpnI digests are presented in Fig. 5 and Fig. 6, respectively 6.6 x 106. Similar conclusions were derived from analyses of the KpnI digests of these recombinants (Fig. 6) . The KpnI digests of RHlG30, RHlG31, RH1G35, and RH1G36 were identical to that of the mutant HSV-1(mhP)tsHA1; therefore, only that of RH1G30 is shown. The KpnI digests of RH1G43, RH1G44, and RH1G47 were identical, consistent with the results of the BamHI digestions. Also, the digests of RHlG13 and RH1G20 were identical. Consistent results were obtained from analyses of the digests of recombinant DNAs with BglII and HpaI restriction endonucleases (not shown).
Analyses of the data indicated that the recombinants formed six groups that differ in the extent of replacement of HSV-1 sequences by HSV-2 sequences (Fig. 7) .
(i) The group exemplified by RHlG30 could not be differentiated from the mutant virus and therefore represented either revertants or recombinants in which the replacement of HSV-1 sequences with HSV-2 sequences was too small to be detected.
(ii) In the group of recombinants exemplified by RH1G8, the maximum extent of replacement of HSV-1 sequences with HSV-2 sequences is defined by the presence of the HSV- the position defined by the absence of the HSV-2 BglII-G-J cleavage site. The maximum right boundary of replacement of HSV-1 sequences with HSV-2 sequences is defined by the absence of the HSV-2 KpnI-G-D cleavage site, and the minimum right boundary is defined by the absence of the HSV-1 HpaI-B-H cleavage site.
(iv) In the group of recombinants exemplified by RH1G48, the maximum extent of replacement of HSV-1 sequences with HSV-2 sequences is defined on the left boundary by the presence of the HSV-1 KpnI-N-P cleavage site and on the right boundary by the presence of the HSV-1 BamHI-V-R site. The miniimum left and right boundaries are both defined by the absence of the HSV-1 BamHI-G-V cleavage site.
(v) In the group of recombinants exemplified by RH1G44, the maximum left boundary is de-R20 R13 RB R7 tsHAI R48 R47 (16) .
fined by the presence of the HSV-1 KpnI-S-N cleavage site, and the minimum is defined by the presence of the HSV-2 KpnI-J-M cleavage site. The maximum right border is the HSV-1 BamHI-R-W cleavage site, and the miniimum is the HSV-1 KpnI-P-V cleavage site.
(vi) The maximum left boundary in the group of recombinants exemplified by RH1G13 is the HSV-1 HpaI-I-V cleavage site, and the minimum left boundary is the HSV-1 HpaI-V-B cleavage site. The maximum right boundary is defined by the HSV-1 BamHI-R-W cleavage site, and the minimum right boundary is the HSV-1 KpnI-P-V cleavage site.
Mapping polypeptide genes specified by HSV-2 sequences in the recombinant genomes within map units 0.28 to 0.48. Mapping of the polypeptide genes was based on known differences in electrophoretic mobility of HSV-1-and HSV-2-specific polypeptides in sodium dodecyl sulfate-polyacrylamide gels (12, 23) . In these experiments, HEp-2 cultures infected with HSV-l(mP), HSV-1(miP)tsHAl, HSV-2(G), and representative tsHAl x HSV-2 (G) recombinants were pulse-labeled with "ICamino acids at various times postinfection. Figure 8 shows the autoradiographic images of the electrophoretically separated ICPs. A summary of the map positions of the ICP templates deduced from these analyses is included in Fig. 7 . The electrophoretic separations shown in Fig.  8 The mapping of the gene specifying ICP 11 is more complex. RH1G7 and RH1G13 both specified HSV-2 ICP 11. Whereas RH1G44 specified an HSV-2 ICP 11, the recombinants RH1G43 and RH1G47 specified an HSV-1 ICP 11. Although no differences in restriction endonuclease patterns were observed, RH1G43 and RH1G47 could have a smaller replacement of HSV-1 sequences with HSV-2 sequences at their borders. Previous studies have also mapped HSV ICP 11 in this region (23) . Because RH1G8 did not specify an HSV-2 ICP 11, the data sug- gested that ICP 11 maps to the left of map position 0.383. Of particular interest was the observation that all recombinants specified an HSV-2 ICP 8. ICP 8 must map, therefore, between 0.383 and 0.402 map units, as defined by the maximum borders of HSV-2 sequences in RH1G48.
Fine mapping of the temperature-sensitive lesion with cloned fragments of HSV-1 DNA. The studies presented above indicated that the lesion maps between map positions 0.383 and 0.402. To obtain a finer localization of the temperature-sensitive lesion, marker rescue experiments were done with the cloned fragment BamHI-G and fragments derived by digestion of this fragment with KpnI and Sall. The results of these studies (Table 2 ) indicated the following. Both intact BamHI-G and the Sall fragment AO, derived by digestion of BamHI fragment G with the restriction enzyme SaII followed by purification of the fragment from agarose gels, rescued the mutant. When the KpnI fragment N, derived by digestion of BamHI-G with the restriction enzyme KpnI followed by purification of the fragment from agarose gels, was used in marker rescue experiments, it yielded viral progeny with an efficiency of plating at 390C only marginally higher than that of the progeny produced by transfection with the mutant DNA alone. From the maps presented in Fig. 1 , we concluded that the mutation mapped between the KpnI-N-P cleavage site at map position 0.383 and the BamHI-G-V cleavage site at map position 0.388.
Translation of RNA homologous to the Sall fragment AO. The purpose of these experiments was to determine the polypeptides whose genes map within the SailI fragment AO, the smallest cloned fragment capable of rescuing the tsHAl mutant. In these experiments, RNA from cells infected with HSV-1(F) and treated with PAA from the time of infection to 10 h postinfection was hybridized to Sall AO and BamHI fragments G, Q, and T. The selected RNA was then translated in the reticulocyte lysate system. The results, shown in Fig. 9 and summarized in Table 3 , were as follows.
(i) Two polypeptides with molecular weights of 128,000 and 25,000 were translated from RNA (ii) The specificity of the selection was evident from the observation that the same two polypeptides were translated from the RNA selected with the BamHI fragment G and from the observation that these polypeptides were not present in the translation products of the RNA selected with BamHI fragments Q and T. BamHI-G translated two additional polypeptides with molecular weights of 114,000 and 105,000. The polypeptide with a molecular weight of 114,000 corresponded to ICP 11, whereas the polypeptide with a molecular weight of 105,000, probably a gpA or gpB precursor, corresponded to ICP 15. (iii) The BamHI fragment Q-selected RNA translated polypeptides with molecular weights of 35,000, 37,000, 42,000, and 150,000. The polypeptide with a molecular weight of 35,000 corresponded to ICP 39, which was previously mapped to the region. The polypeptide with a molecular weight of 37,000 corresponded to ICP 37, which was mapped to the region by the intertypic recombinants presented in this study. Studies to be presented elsewhere indicate that ICP 37 forms two bands a and b, corresponding to a precursor and product. The polypeptide with a molecular weight of 42,000 corresponded to ICP 36, the HSV thymidine kinase. Both ICP 36 and the thymidine kinase have been previously mapped within the BamHI fragment Q. The polypeptide with a molecular weight of 150,000 corresponded to ICP 5, based on both its electrophoretic mobility and map location. Previous studies have shown that a large portion of the gene specifying ICP 5 maps between 0.23 and 0.29 map units, and indeed the RNA selected by the BamHI fragment T translated ICP 5. The RNA selected by this fragment also translated a polypeptide with an approximate molecular weight of 70,000 which may correspond to one of the polypeptides which map in the region. ICP 24, molecular weight 68,000, was previously mapped in that region.
DISCUSSION
In this paper we report on the characterization of a mutant isolated by mutagenesis of a specific fragment of the HSV DNA.
Production of the temperature-sensitive mutant. The HSV-l(mhP)tsHAl mutant was produced by hydroxylamine mutagenesis of an HSV-1 fragment. Unlike the mutants previously produced by Chu et al. (6) , the concentration of hydroxylamine used in this study was 100 times lower to reduce the probability of secondary mutations within the mutagenized fragment. Consistently, we isolated only one mutant from 300 plaques screened from the progeny of the transfection of intact DNA and the mutagenized fragment.
Mapping of the ts mutation. The mapping of the temperature-sensitive mutation was done to verify that the mutation was within the mutagenized fragment and to localize the mutation within the narrowest possible limits permitted by the procedures employed in this study. Marker rescue with HSV-2 DNA fragments indicated that the mutation was within the HSV- Fig. 3 , indicated that the electrophoretic pattern at the permissive temperature could not be differentiated from that of cells infected with wild-type virus. This observation was consistent with the expectation that mutants produced by site-or fragment-specific mutagenesis should not contain secondary, nonlethal mutations in genes residing elsewhere in the genome which could affect the pattern of synthesis of polypeptides. Identification of the gene product containing the temperature-sensitive lesion. Analyses of recombinants produced by marker rescue with HSV-2 DNA digests showed that ICP 8 was the only HSV-2 polypeptide specified by all the recombinants containing detectable HSV-2 DNA sequences. Inasmuch as additional polypeptides specified by the HSV-2 sequences in the recombinant genomes may have electrophoretic mobilities identical to their HSV-1 counterparts, we then proceeded to translate RNA selected by hybridization to the smallest available HSV-1 DNA fragment carrying the sequences which rescued the mutant. The data show that two polypeptides ICP 8 and a previously undetected polypeptide with a molecular weight of 25,000 mapped within the region of the genome rescuing the mutation.
Several points in connection with these results should be noted. (i) The RNA selected for these studies was prepared in PAA-treated cells. Because the shutoff of /8 polypeptide synthesis is delayed both in PAA-treated cells infected with wild-type virus and in cells infected with the tsHAl mutant virus at the nonpermissive temperature, we could expect a larger than normal accumulation of transcripts from /3 genes, including the gene bearing the ts mutant. Therefore, if mRNA's specifying other / polypeptides map in that region, they should have been detected. It should be noted parenthetically that other fragments of HSV DNA, used as controls, selected RNAs that specified other polypeptides which in untreated infected cells accumulate in both abundant and scarce amounts.
(ii) The 25,000-molecular-weight polypeptide was not previously detected. It is conceivable that a polypeptide with that molecular weight could comigrate with ICP 43. Although it has been known that HSV-1 ICP 8 is a /3 polypeptide with strong binding affinity for viral DNA (2, 28, 37), it has not been previously known that its function is required for viral DNA synthesis. The molecular weight of ICP 8 (128,000) is less than the reported molecular weight of the HSV DNA polymerase (26) . It should be noted parenthetically that two complementation groups involving ts mutations in the viral DNA polymerase have been reported (5) . Representative mutants from each group have been mapped by marker rescue but not by the RNA selection and translation technique used in this study. Although the polypeptide carrying the ts DNA polymerase lesion has not been identified, these mutants appear to map to the right of the tsHAl mutation (5). These observations appear to reinforce our conclusion that the mutation in tsHAl was not in the viral DNA polymerase.
(iii) Analyses of the recombinants produced by marker rescue with HSV-2 DNA digests have more precisely localized the map locations of HSV genes previously mapped. These are genes for ICPs 36, 35, 2, 43, and 44. In addition, these studies localized the genes specifying two polypeptides, ICP 37 and ICP 19.5 with molecular weights of 40,000 and 84,000, respectively, which have not been previously mapped. The ICP 19.5 is of particular interest because the band containing ICP 19 was considered to contain a single polypeptide. ICP 19.5, produced in more abundant amounts 10 to 12 h postinfection, had not been previously detected. Our data also suggested that ICP 11 maps in close vicinity to, and probably to the left of the ICP 8 gene.
